422 related articles for article (PubMed ID: 35735269)
1. A combination strategy of structure-based virtual screening, MM-GBSA, cross docking, molecular dynamics and metadynamics simulations used to investigate natural compounds as potent and specific inhibitors of tumor linked human carbonic anhydrase IX.
Chahal V; Kakkar R
J Biomol Struct Dyn; 2023; 41(12):5465-5480. PubMed ID: 35735269
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of the binding modes of SLC-0111 and its analogues in the hCA II and hCA IX active sites using QM/MM, molecular docking, MM-GBSA and MD approaches.
Chahal V; Nirwan S; Kakkar R
Biophys Chem; 2020 Oct; 265():106439. PubMed ID: 32738591
[TBL] [Abstract][Full Text] [Related]
3. A selectivity study of benzenesulfonamide derivatives on human carbonic anhydrase II/IX by 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation.
Wang Y; Guo H; Tang G; He Q; Zhang Y; Hu Y; Wang Y; Lin Z
Comput Biol Chem; 2019 Jun; 80():234-243. PubMed ID: 31009872
[TBL] [Abstract][Full Text] [Related]
4. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
[TBL] [Abstract][Full Text] [Related]
5. Identification of potent human carbonic anhydrase IX inhibitors: a combination of pharmacophore modeling, 3D-QSAR, virtual screening and molecular dynamics simulations.
Chahal V; Nirwan S; Pathak M; Kakkar R
J Biomol Struct Dyn; 2022 Jul; 40(10):4516-4531. PubMed ID: 33317405
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel CA IX inhibitor: Pharmacophore modeling, docking, DFT, and dynamic simulation.
Packiapalavesam SD; Saravanan V; Mahajan AA; Almutairi MH; Almutairi BO; Arockiaraj J; Kathiravan MK; Karthick Raja Namasivayam S
Comput Biol Chem; 2024 Jun; 110():108073. PubMed ID: 38678727
[TBL] [Abstract][Full Text] [Related]
7. S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors.
El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Alanazi MM; El-Gendy MA; Ahmed HEA; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):733-743. PubMed ID: 32189526
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors.
Buza A; Türkeş C; Arslan M; Demir Y; Dincer B; Nixha AR; Beydemir Ş
Int J Biol Macromol; 2023 Jun; 239():124232. PubMed ID: 37001773
[TBL] [Abstract][Full Text] [Related]
9. New thiopyrimidine-benzenesulfonamide conjugates as selective carbonic anhydrase II inhibitors: synthesis, in vitro biological evaluation, and molecular docking studies.
Abdel-Mohsen HT; El Kerdawy AM; Omar MA; Berrino E; Abdelsamie AS; El Diwani HI; Supuran CT
Bioorg Med Chem; 2020 Mar; 28(5):115329. PubMed ID: 32007388
[TBL] [Abstract][Full Text] [Related]
10. Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX.
Mikuš P; Krajčiová D; Mikulová M; Horváth B; Pecher D; Garaj V; Bua S; Angeli A; Supuran CT
Bioorg Chem; 2018 Dec; 81():241-252. PubMed ID: 30153589
[TBL] [Abstract][Full Text] [Related]
11. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
[TBL] [Abstract][Full Text] [Related]
12. Exploration of 1,2,3-triazole linked benzenesulfonamide derivatives as isoform selective inhibitors of human carbonic anhydrase.
Kakakhan C; Türkeş C; Güleç Ö; Demir Y; Arslan M; Özkemahlı G; Beydemir Ş
Bioorg Med Chem; 2023 Jan; 77():117111. PubMed ID: 36463726
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
[TBL] [Abstract][Full Text] [Related]
14. Discovery of new carbonic anhydrase IX inhibitors as anticancer agents by toning the hydrophobic and hydrophilic rims of the active site to encounter the dual-tail approach.
Tawfik HO; Petreni A; Supuran CT; El-Hamamsy MH
Eur J Med Chem; 2022 Mar; 232():114190. PubMed ID: 35182815
[TBL] [Abstract][Full Text] [Related]
15. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A
J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095
[TBL] [Abstract][Full Text] [Related]
16. Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX/XII inhibitors.
Ghorab MM; Soliman AM; Bua S; Supuran CT
Bioorg Chem; 2021 Feb; 107():104618. PubMed ID: 33485104
[TBL] [Abstract][Full Text] [Related]
17. Identification of Novel and Potent Indole-Based Benzenesulfonamides as Selective Human Carbonic Anhydrase II Inhibitors: Design, Synthesis, In Vitro, and In Silico Studies.
Elkamhawy A; Woo J; Nada H; Angeli A; Bedair TM; Supuran CT; Lee K
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269684
[TBL] [Abstract][Full Text] [Related]
18. 5-Arylisothiazol-3(2H)-one-1,(1)-(di)oxides: A new class of selective tumor-associated carbonic anhydrases (hCA IX and XII) inhibitors.
Cornelio B; Laronze-Cochard M; Miambo R; De Grandis M; Riccioni R; Borisova B; Dontchev D; Machado C; Ceruso M; Fontana A; Supuran CT; Sapi J
Eur J Med Chem; 2019 Aug; 175():40-48. PubMed ID: 31071549
[TBL] [Abstract][Full Text] [Related]
19. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment.
El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Almehizia AA; Alanazi MM; Hefnawy MM; Supuran CT
Eur J Med Chem; 2019 Nov; 181():111573. PubMed ID: 31394463
[TBL] [Abstract][Full Text] [Related]
20. Novel 8-Substituted Coumarins That Selectively Inhibit Human Carbonic Anhydrase IX and XII.
Buran K; Bua S; Poli G; Önen Bayram FE; Tuccinardi T; Supuran CT
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
